Effect of magnesium treatment and glucose levels on delayed cerebral ischemia in patients with subarachnoid hemorrhage: A substudy of the Magnesium in Aneurysmal Subarachnoid Haemorrhage trial (MASH-II)

dc.creatorLeijenaar, Jolien F.
dc.creatorDorhout Mees, Sanne M.
dc.creatorAlgra, Ale
dc.creatorvan den Bergh, Walter M.
dc.creatorRinkel, Gabriel J.E.
dc.creatorDorhout Mees, S. M.
dc.creatorvan den Bergh, W. M.
dc.creatorRinkel, G. J.E.
dc.creatorAlgra, A.
dc.creatorvan Buuren, M.
dc.creatorAl-Shahi Salman, R.
dc.creatorBoiten, J.
dc.creatorvan Kooten, F.
dc.creatorKuijsten, H.
dc.creatorLavados Germain, Pablo Manuel
dc.date.accessioned2019-03-18T11:53:39Z
dc.date.available2019-03-18T11:53:39Z
dc.date.created2019-03-18T11:53:39Z
dc.date.issued2015
dc.identifierInternational Journal of Stroke, Volumen 10, Issue A100, 2018, Pages 108-112
dc.identifier17474949
dc.identifier17474930
dc.identifier10.1111/ijs.12621
dc.identifierhttps://repositorio.uchile.cl/handle/2250/166687
dc.description.abstract© 2015 World Stroke Organization. Background: Magnesium treatment did not improve outcome in patients with aneurysmal subarachnoid haemorrhage in the Magnesium in Aneurysmal Subarachnoid Haemorrhage II trial. We hypothesized that high glucose levels may have offset a potential beneficial effect to prevent delayed cerebral ischemia. We investigated if magnesium treatment led to less delayed cerebral ischemia and if glucose levels interacted with magnesium treatment in the Magnesium in Aneurysmal Subarachnoid Haemorrhage II trial. Aim: To investigate the effect of magnesium treatment on occurrence of delayed cerebral ischemia and the interaction between glucose levels and magnesium treatment in subarachnoid hemorrhage patients. Methods: The Magnesium in Aneurysmal Subarachnoid Haemorrhage was a phase III randomized placebo-controlled trial assessing the effect of magnesium sulphate on clinical outcome in aneurysmal subarachnoid hemorrhage patients. For the current study, we included only
dc.languageen
dc.publisherBlackwell Publishing Ltd
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceInternational Journal of Stroke
dc.subjectDCI
dc.subjectDelayed cerebral ischemia
dc.subjectGlucose
dc.subjectMagnesium
dc.subjectSAH
dc.subjectSubarachnoid hemorrhage
dc.titleEffect of magnesium treatment and glucose levels on delayed cerebral ischemia in patients with subarachnoid hemorrhage: A substudy of the Magnesium in Aneurysmal Subarachnoid Haemorrhage trial (MASH-II)
dc.typeArtículo de revista


Este ítem pertenece a la siguiente institución